Target intelligence / Profile preview

Proteoglycan synthesis and secretion in endothelial cells

Molecular classification
Other
01

Overview

Proteoglycan synthesis and secretion in endothelial cells is a complex biological process responsible for the production of the endothelial glycocalyx and the vascular extracellular matrix (Source: PubMed 17604508). This process involves the transcription of core proteins, such as syndecans, perlecan, and versican, and the subsequent enzymatic addition of glycosaminoglycan (GAG) chains in the Golgi apparatus (Source: PubMed 1908458). These proteoglycans are critical for maintaining the vascular permeability barrier, regulating inflammation by modulating leukocyte adhesion, and sequestering growth factors (Source: PubMed 23603541). In pathological states like atherosclerosis and diabetes, the synthesis and secretion of these molecules are altered, leading to increased lipid retention and vascular wall thickening (Source: PubMed 15142754). While not a single molecular target, this pathway is modulated by various drugs, including statins and endothelin receptor antagonists, which can alter the composition and quantity of secreted proteoglycans to improve vascular function (Source: PubMed 11566922, 25349199). Understanding the regulation of this process is crucial for developing therapies aimed at restoring the endothelial glycocalyx and preventing cardiovascular complications.

Other names
Endothelial proteoglycan metabolismGlycocalyx assemblyProteoglycan biosynthesisEndothelial glycocalyx synthesis
02

Mechanism of action

Modulation of the expression and activity of enzymes involved in glycosaminoglycan chain assembly and core protein synthesis (Source: PubMed 11566922).

03

Biological functions

Extracellular matrix organizationVascular permeabilityCell adhesionSignal transductionVascular homeostasis
04

Disease associations

AtherosclerosisDiabetes mellitusCardiovascular diseaseInflammationCancer metastasis
05

Safety considerations

Disruption of systemic extracellular matrix integrityPotential for off-target effects on non-vascular proteoglycansAlterations in growth factor signalingPotential impact on wound healing
06

Interacting drugs

Atorvastatin

3 more in the full profile.

07

Biomarkers

Syndecan-1Heparan sulfateBiglycanVersicanHyaluronan

Beyond the preview

Go deeper on Proteoglycan synthesis and secretion in endothelial cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteoglycan synthesis and secretion in endothelial cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call